Revolution Medicines Inc
(RVMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 12,661 | 10,025 | 11,546 | 12,088 | 12,506 |
| Gross Profit | 12,661 | 10,025 | 11,546 | 12,088 | 12,506 |
| Operating Expenses | 40,212 | 38,009 | 32,628 | 31,652 | 26,065 |
| Operating Income | -27,551 | -27,984 | -21,082 | -19,564 | -13,559 |
| Interest Expense | 17 | 19 | 21 | 23 | 25 |
| Other Income | 347 | 730 | 909 | 618 | 766 |
| Pre-tax Income | -27,221 | -27,273 | -20,194 | -18,969 | -12,818 |
| Income Tax | N/A | -58 | -675 | -4,373 | N/A |
| Net Income Continuous | -27,221 | -27,215 | -19,519 | -14,596 | -12,818 |
| Net Income | $-27,221 | $-27,215 | $-19,519 | $-14,596 | $-12,818 |
| EPS Basic Total Ops | -0.42 | -0.46 | -0.74 | -6.56 | -6.08 |
| EPS Basic Continuous Ops | -0.42 | -0.46 | -0.67 | -5.07 | -4.57 |
| EPS Diluted Total Ops | -0.42 | -0.46 | -0.74 | -6.56 | -6.08 |
| EPS Diluted Continuous Ops | -0.42 | -0.46 | -0.67 | -5.07 | -4.57 |
| EBITDA(a) | $-25,521 | $-26,226 | $-19,643 | $-18,842 | $-12,905 |